FDA gives patients hope after approving brain cancer drug with Duke ties The Citizen 1 year ago The FDA approved vorasidenib earlier this month for adult and pediatric patients 12 and older with Grade2 astrocytoma or oligodendroglioma. Source: WRAL News Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on LinkedIn (Opens in new window) LinkedIn Share on Pinterest (Opens in new window) Pinterest Share on WhatsApp (Opens in new window) WhatsApp Alzheimer's drug from Biogen, partner receives FDA approvalDateJanuary 6, 2023In relation toMarshallbergRaleigh drug firm lands FDA approval for treatment of intestinal infection affecting millionsDateNovember 4, 2019In relation toNewsIf FDA approves Pfizer vaccine, Duke could get first doses immediatelyDateDecember 10, 2020In relation toNews
